P2X Receptor
P2XRs
P2X receptors are a family of seven (P2X1R-P2X7R) cation permeable ligand-gated ion channels (LGICs) that open in response to binding by the extracellular ligand, adenosine 5′-triphosphate (ATP). P2X receptors have a high permeability to Ca2+, Na+, and K+ and are expressed widely throughout the nervous, immune, cardiovascular, skeletal, gastrointestinal, respiratory, and endocrine systems.
P2X receptors are widely expressed in excitatory and non-excitatory cells, such as neuron, glia, platelet, epithelia and macrophage, and participate in many important physiological and pathological processes, including synaptic transmission, pain perception, inflammation, cardiovascular modulation, immunomodulation and tumorigenesis.
P2X Receptor Isoform Specific Products
All Product Categories
-
P2X Receptor Related Products (156)
Related Products (156)
-
P2X Receptor Isoform Comparison
-
ITH15004
0 ImagesCat. No.: HY-156986CAS No.: 2600675-12-3ITH15004 is a CNS-penetrated P2X7 antagonist, used for the study of neurodegenerative diseases.
-
SMW139
0 ImagesCat. No.: HY-171462CAS No.: 2133010-38-3SMW139 is a selective allosteric antagonist of P2X7 receptor, with a Ki value of 32 nM for human P2X7R. The half-life of SMW139 in rat liver microsomes is 47 minutes. SMW139 can be used for inflammation, Alzheimer’s disease, multiple sclerosis study.
-
α,β-Methylene-ATP trisodium (Standard)
0 ImagesCat. No.: HY-108652RCAS No.: 1343364-54-4α,β-Methylene-ATP trisodium (Standard) is the analytical standard of α,β-Methylene-ATP (trisodium) (HY-108652). This product is intended for research and analytical applications. α,β-Methylene-ATP trisodium is an agonist of P2X1 and P2X3 receptors and can cross the blood-brain barrier. α,β-Methylene-ATP trisodium can trigger a reflex pressor response by activating P2X receptors in peripheral muscles and the central locus coeruleus (LC); this effect can be blocked by the P2X antagonist PPADS (HY-108960). α,β-Methylene-ATP trisodium also activates noradrenergic neurons in the central locus coeruleus, mediating antinociceptive effects; this effect can be attenuated by the locus coeruleus damaging agent DSP-4 (HY-103210/HY-121602). α,β-Methylene-ATP trisodium can be used to study the pathological mechanisms of neuropathic pain, cardiovascular reflex regulation, and antinociceptive effects of the central nervous system.
-
Opiranserin hydrochloride (Standard)
0 ImagesCat. No.: HY-109067ARCAS No.: 1440796-75-7Synonyms: VVZ-149 hydrochloride (Standard)Opiranserin hydrochloride (Standard) is the analytical standard of Opiranserin (hydrochloride) (HY-109067A). This product is intended for research and analytical applications. Opiranserin (VVZ-149) hydrochloride, a non-opioid and non-NSAID analgesic candidate, is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A), with IC50s of 0.86 and 1.3 μM, respectively. Opiranserin hydrochloride shows antagonistic activity on rP2X3 (IC50=0.87 μM). Opiranserin hydrochloride is development as an injectable agent for the treatment of postoperative pain.
-
Piromelatine (Standard)
0 ImagesSynonyms: Neu-P11 (Standard)Piromelatine (Standard) is the analytical standard of Piromelatine. This product is intended for research and analytical applications. Piromelatine (Neu-P11) is a melatonin MT1/MT2 receptor agonist, serotonin 5-HT1A/5-HT1D agonist, and serotonin 5-HT2B antagonist. Piromelatine (Neu-P11) possesses sleep promoting, analgesic, anti-neurodegenerative, anxiolytic and antidepressant potentials. Piromelatine (Neu-P11) also possesses pain-related P2X3, TRPV1, and Nav1.7 channel-inhibition capacities.
-
Uridine adenosine tetraphosphate
0 ImagesCat. No.: HY-137606CAS No.: 10527-48-7Synonyms: UP4A
-
Gefapixant (Standard)
0 ImagesSynonyms: MK-7264 (Standard); AF-219 (Standard)Gefapixant (Standard) is the analytical standard of Gefapixant. This product is intended for research and analytical applications. Gefapixant is an orally active and potent purinergic P2X3 receptor (P2X3R) antagonist, with IC50 values of ~30 nM versus recombinant hP2X3 homotrimers and 100-250 nM at hP2X2/3 heterotrimeric receptors. Gefapixant can be used for the research of chronic cough and knee osteoarthritis.
-
Eliapixant (Standard)
0 ImagesCat. No.: HY-109170RCAS No.: 1948229-21-7Synonyms: BAY 1817080 (Standard)Eliapixant (Standard) is the analytical standard of Eliapixant (HY-109170). This product is intended for research and analytical applications. Eliapixant (BAY 1817080) is a potent and selective antagonist of P2X3 receptor, with an IC50 of 8 nM. Eliapixant can be used for the research of refractory chronic cough.
-
NF449
0 ImagesCat. No.: HY-112461CAS No.: 389142-38-5NF449 is a highly potent P2X1 receptor antagonist, with IC50s of 0.28, 0.69, and 120 nM for rP2X1, rP2X1+5, P2X2+3, respectively. NF449 is a Gsα-selective G Protein antagonist. NF449 suppresses the rate of GTP[γS] binding to Gsα-s, inhibits the stimulation of adenylyl cyclase activity, and blocks the coupling of β-adrenergic receptors to Gs.
-
AZ 11645373 (Standard)
0 ImagesCat. No.: HY-108670RCAS No.: 227088-94-0AZ 11645373 (Standard) is the analytical standard of AZ 11645373 (HY-108670). This product is intended for research and analytical applications. AZ11645373 is a highly selective and potent antagonist at human but not rat P2X7 receptors，AZ11645373 inhibits ATP-evoked IL-1β release from lipopolysaccharide-activated THP-1 cells , with an IC50 value of 90 nM.
-
BX430 (Standard)
0 ImagesCat. No.: HY-110237RCAS No.: 688309-70-8BX430 (Standard) is the analytical standard of BX430 (HY-110237). This product is intended for research and analytical applications. BX430 is a potent and selective noncompetitive allosteric human P2X4 receptor channels antagonist with an IC50 of 0.54 μM. BX430 has species specificity. BX430 is used for chronic pain and cardiovascular disease.
-
P2X4 antagonist-5
0 ImagesP2X4 antagonist-5 (compound 63) is a control compound for P2X4 antagonists (IC50>100 μM, hP2X4).
-
JNJ-47965567 (Standard)
0 ImagesCat. No.: HY-101418RCAS No.: 1428327-31-4JNJ-47965567 (Standard) is the analytical standard of JNJ-47965567 (HY-101418). This product is intended for research and analytical applications. JNJ-47965567 is a centrally permeable, high-affinity, selective P2X7 antagonist, with pKis of 7.9 and 8.7 for human and rat P2X7, respectively. JNJ-47965567 can be used to probe the role of central P2X7 in rodent models of CNS pathophysiology.
-
Filapixant (Standard)
0 ImagesCat. No.: HY-109173RCAS No.: 1948232-63-0Synonyms: BAY 1902607 (Standard)Filapixant (Standard) is the analytical standard of Filapixant (HY-109173). This product is intended for research and analytical applications. Filapixant is a purinoreceptor antagonist extracted from patent WO2016091776A1, example 348. Filapixant is the active reference substance of Eliapixant.
-
Oxatomide (Standard)
0 ImagesCat. No.: HY-123205RCAS No.: 60607-34-3Synonyms: KW-4354 (Standard)Oxatomide (Standard) (KW-4354 (Standard)) is the analytical standard of Oxatomide (HY-123205). This product is intended for research and analytical applications. Oxatomide (KW-4354) is an orally active dual antagonist of the H1-histamine receptor and the P2X7 receptor, as well as an inhibitor of serotonin. Oxatomide possesses antihistaminic, antiallergic and anti-inflammatory activities. Oxatomide can be used in the research of allergic diseases.
-
TC-P 262
0 ImagesCat. No.: HY-108668CAS No.: 873398-67-5TC-P 262 is a potent P2X3 inhibitor. TC-P 262 shows inhibition by bindings to hP2X3. TC-P 262 has the potential for the research of rheumatoid arthritis, cough, and pain.
